S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works

Virological assessment of hospitalized patients with COVID-2019

Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

Antibody responses to SARS-CoV-2 in patients with COVID-19

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876 · see citing works

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686 · see citing works

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477 · see citing works

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Wu, A., Peng, Y., Huang, B., Ding, X. L., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,363 · see citing works

Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals

Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853 · see citing works

A serological assay to detect SARS-CoV-2 seroconversion in humans

Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769 · see citing works

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310 · see citing works

SARS-CoV-2 Vaccines: Status Report

Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120 · see citing works

B Cell Responses: Cell Interaction Dynamics and Decisions

Cyster, J. G., & Allen, C. D. C. (2019) · Cell · doi:10.1016/j.cell.2019.03.016 · Cited by 974 · see citing works

A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2

Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 920 · see citing works

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886 · see citing works

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Premkumar, L., Segovia-Chumbez, B., Jadi, R., Martinez, D. R., Raut, R., Markmann, A. J., Cornaby, C., Bartelt, L., Weiss, S., Park, Y., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc8413 · Cited by 868 · see citing works

Cutting edge: long-term B cell memory in humans after smallpox vaccination

Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4969 · Cited by 695 · see citing works

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., et al. (2020) · Science · doi:10.1126/science.abc7424 · Cited by 520 · see citing works

Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop

Jaimes, J. A., André, N. M., Chappie, J. S., Millet, J. K., & Whittaker, G. R. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.04.009 · Cited by 485 · see citing works

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Sun, B., Feng, Y., Mo, X., Zheng, P., Wang, Q., Li, P., Peng, P., Liu, X., Chen, Z., Huang, H., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1762515 · Cited by 473 · see citing works

Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019

Burbelo, P. D., Riedo, F. X., Morishima, C., Rawlings, S. A., Smith, D. M., Das, S., Strich, J. R., Chertow, D. S., Davey, R. T., & Cohen, J. I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa273 · Cited by 466 · see citing works

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

Buchholz, U. J., Bukreyev, A. A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385 · see citing works

Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination

Ellebedy, A. H., Jackson, K., Kissick, H. T., Nakaya, H. I., Davis, C. W., Roskin, K. M., McElroy, A. K., Oshansky, C. M., Elbein, R., Thomas, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3533 · Cited by 384 · see citing works

Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S

Quataert, S. A., Kirch, C. S., Wiedl, L. J., Phipps, D. C., Strohmeyer, S., Cimino, C. O., Skuse, J., & Madore, D. V. (1995) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.2.5.590-597.1995 · Cited by 266 · see citing works

COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva

Pisanic, N., Randad, P., Kruczynski, K., Manabe, Y. C., Thomas, D. L., Pekosz, A., Klein, S., Betenbaugh, M. J., Clarke, W., Laeyendecker, O., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02204-20 · Cited by 244 · see citing works

The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans

Johnson, J. L., Rosenthal, R. L., Knox, J. J., Myles, A., Naradikian, M. S., Madej, J., Kostiv, M., Rosenfeld, A. M., Meng, W., Christensen, S. R., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.020 · Cited by 212 · see citing works

Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral Nucleocapsid

Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L. K., Niu, H., Tam, J. S., & Lim, P. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/422040 · Cited by 207 · see citing works

Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing

Elshabrawy, H. A., Coughlin, M. M., Baker, S. C., & Prabhakar, B. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050366 · Cited by 173 · see citing works

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross‐Reactivity with SARS Coronavirus

Patrick, D. M., Petric, M., Skowronski, D. M., Guasparini, R., Booth, T. F., Krajden, M., McGeer, P. L., Bastien, N., Gustafson, L., Dubord, J., et al. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/152612 · Cited by 152 · see citing works

Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin

Andrews, S. F., Chambers, M. J., Schramm, C. A., Plyler, J. R., Raab, J. E., Kanekiyo, M., Gillespie, R. A., Ransier, A., Darko, S. W., Hu, J., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.024 · Cited by 141 · see citing works

Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures

Galson, J. D., Schätzle, S., Bashford-Rogers, R. J. M., Raybould, M. I. J., Kovaltsuk, A., Kilpatrick, G. J., Minter, R., Finch, D. K., Dias, J. C., James, L. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.605170 · Cited by 140 · see citing works

Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia

Joo, H. M., He, Y., & Sangster, M. Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800003105 · Cited by 91 · see citing works

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humansPreprint

Ng, K. W., Faulkner, N., Cornish, G. H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.14.095414 · Cited by 85 · see citing works

COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in salivaPreprint

Randad, P. R., Pisanic, N., Kruczynski, K. L., et al. (2020) · medRxiv · doi:10.1101/2020.05.24.20112300 · Cited by 80 · see citing works

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus

Tesini, B. L., Kanagaiah, P., Wang, J., Hahn, M. A., Halliley, J. L., Chaves, F. A., Nguyen, P. Q. T., Nogales, A., DeDiego, M. L., Anderson, C., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00169-19 · Cited by 51 · see citing works

High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections

Weiss, G. E., Ndungu, F. M., McKittrick, N. D., Li, S., Kimani, D., Crompton, P. D., Marsh, K., & Pierce, S. K. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.09.006 · Cited by 32 · see citing works

Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signaturesPreprint

Galson, J. D., Schaetzle, S., Bashford-Rogers, R. J. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.20.106294 · Cited by 28 · see citing works

Role of Memory B Cells in Hemagglutinin-Specific Antibody Production Following Human Influenza A Virus Infection

Sangster, M. Y., Nguyen, P. Q. T., & Topham, D. J. (2019) · Pathogens · doi:10.3390/pathogens8040167 · Cited by 24 · see citing works

Adaptive immunity to SARS-CoV-2 and COVID-19

Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886 · see citing works

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · Science · doi:10.1126/science.abm0829 · Cited by 873 · see citing works

COVID-19 vaccine development: milestones, lessons and prospects

Li, M., Wang, H., Tian, L., Pang, Z., Yang, Q., Huang, T., Fan, J., Song, L., Tong, Y., & Fan, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00996-y · Cited by 448 · see citing works

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Anderson, E. M., Goodwin, E. C., Verma, A., Arevalo, C. P., Bolton, M. J., Weirick, M. E., Gouma, S., McAllister, C. M., Christensen, S. R., Weaver, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.010 · Cited by 369 · see citing works

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.050 · Cited by 340 · see citing works

Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19

Pace, R. M., Williams, J. E., Järvinen, K. M., Belfort, M. B., Pace, C. D. W., Lackey, K. A., Gogel, A. C., Nguyen-Contant, P., Kanagaiah, P., Fitzgerald, T., et al. (2021) · mBio · doi:10.1128/mbio.03192-20 · Cited by 315 · see citing works

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Hartley, G. E., Edwards, E. S. J., Aui, P. M., Varese, N., Stojanovic, S., McMahon, J., Peleg, A. Y., Boo, I., Drummer, H. E., Hogarth, P. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abf8891 · Cited by 296 · see citing works

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 239 · see citing works

Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors

Shroff, R. T., Chalasani, P., Wei, R., Pennington, D., Quirk, G., Schoenle, M. V., Peyton, K. L., Uhrlaub, J. L., Ripperger, T. J., Jergović, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01542-z · Cited by 233 · see citing works

Immunological imprinting of the antibody response in COVID-19 patients

Aydillo, T., Rombauts, A., Stadlbauer, D., Aslam, S., Abelenda-Alonso, G., Escalera, A., Amanat, F., Jiang, K., Krammer, F., Carratala, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23977-1 · Cited by 223 · see citing works

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses

Murray, S. M., Ansari, M. A., Frater, J., Klenerman, P., Dunachie, S. J., Barnes, E. J., & Ogbe, A. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00809-x · Cited by 168 · see citing works

COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options

van Eijk, L. E., Binkhorst, M., Bourgonje, A. R., Offringa, A. K., Mulder, D. J., Bos, E. M., Kolundžić, N., Abdulle, A. E., van der Voort, P. H. J., Rikkert, M. G. M. O., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5642 · Cited by 153 · see citing works

Antibody and B cell responses to SARS-CoV-2 infection and vaccination

Röltgen, K., & Boyd, S. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.009 · Cited by 136 · see citing works

The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic

Shah, P., Canziani, G., Carter, E. P., & CHAIKEN, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637651 · Cited by 109 · see citing works

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

Dobaño, C., Santano, R., Jiménez, A., Vidal, M., Chi, J., Melero, N. R., Popovic, M., López-Aladid, R., Fernández‐Barat, L., Tortajada, M., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.02.006 · Cited by 105 · see citing works

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors

Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 113 · see citing works

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response

Lin, C.-Y., Wolf, J., Brice, D. C., Sun, Y., Locke, M., Cherry, S., Castellaw, A. H., Wehenkel, M., Crawford, J. C., Zarnitsyna, V. I., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.12.005 · Cited by 99 · see citing works

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

Grobben, M., van der Straten, K., Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre‐Bosquet, N., Appelman, B., Lavell, A. H. A., van Vught, L. A., Burger, J. A., et al. (2021) · eLife · doi:10.7554/elife.70330 · Cited by 100 · see citing works

Stabilized coronavirus spike stem elicits a broadly protective antibody

Hsieh, C., Werner, A. P., Leist, S. R., Stevens, L. J., Falconer, E., Goldsmith, J. A., Chou, C., Abiona, O. M., West, A., Westendorf, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109929 · Cited by 99 · see citing works

COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain

Secchi, M., Bazzigaluppi, E., Brigatti, C., Marzinotto, I., Tresoldi, C., Rovere, P. Q., Poli, A., Castagna, A., Scarlatti, G., Zangrillo, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142804 · Cited by 94 · see citing works

Why Does the Severity of COVID-19 Differ With Age?

Zimmermann, P., & Curtis, N. C. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003413 · Cited by 86 · see citing works

Early cross-coronavirus reactive signatures of humoral immunity against COVID-19

Kapłonek, P., Wang, C., Bartsch, Y. C., Fischinger, S., Gorman, M. J., Bowman, K. A., Kang, J., Dayal, D., Martin, P., Nowak, R. P., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj2901 · Cited by 76 · see citing works

The role of B cells in COVID-19 infection and vaccination

Chen, S., Guan, F., Candotti, F., Benlagha, K., Câmara, N. O. S., Herrada, A. A., James, L. K., Lei, J., Miller, H., Kubo, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988536 · Cited by 74 · see citing works

Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

Huang, K.-Y. A., Tan, T., Chen, T.-H., Huang, C.-G., Harvey, R., Hussain, S., Chen, C.-P., Harding, A. C., Gilbert-Jaramillo, J., Liu, X., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009352 · Cited by 64 · see citing works

Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?

Hamady, A., Lee, J., & Loboda, Z. (2021) · Infection · doi:10.1007/s15010-021-01664-z · Cited by 65 · see citing works

Pathophysiological, immunological, and inflammatory features of long COVID

Böhmwald, K., Diethelm‐Varela, B., Rodríguez‐Guilarte, L., Rivera, T., Riedel, C. A., González, P. A., & Kalergis, A. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341600 · Cited by 75 · see citing works

Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients

Moura, A. D., da Costa, H. H. M., Correa, V. A., Lima, A. K. D. S., Lindoso, J. Â. L., Gaspari, E. D., Hong, M. A., Cunha-Junior, J. P., & Prudêncio, C. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-95045-z · Cited by 68 · see citing works

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

Woudenberg, T., Pelleau, S., Anna, F., Attia, M., Donnadieu, F., Gravet, A., Lohmann, C., Séraphin, H., Guihéneuf, R., Delamare, C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103495 · Cited by 63 · see citing works

B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19

Wildner, N. H., Ahmadi, P., Schulte, S., Brauneck, F., Kohsar, M., Lütgehetmann, M., Beisel, C., Addo, M. M., Haag, F., & Wiesch, J. S. Z. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5cova0620-370rr · Cited by 64 · see citing works

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses

Siggins, M. K., Thwaites, R. S., & Openshaw, P. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.016 · Cited by 56 · see citing works

Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination

Bellusci, L., Grubbs, G., Zahra, F. T., Forgacs, D., Golding, H., Ross, T. M., & Khurana, S. (2022) · Nature Communications · doi:10.1038/s41467-022-32298-w · Cited by 56 · see citing works

SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals

Ruggiero, A., Piubelli, C., Calciano, L., Accordini, S., Valenti, M. T., Carbonare, L. D., Siracusano, G., Lopalco, L., Temperton, N. J., Tiberti, N., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103888 · Cited by 59 · see citing works

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of ConcernPreprint

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.23.457229 · Cited by 59 · see citing works

Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses

Feldman, J. E., Bals, J., Altomare, C. G., Denis, K. S., Lam, E. C., Hauser, B. M., Ronsard, L., Sangesland, M., Moreno, T. B., Okonkwo, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl5842 · Cited by 58 · see citing works

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses

Halfmann, P., Frey, S. J., Loeffler, K., Kuroda, M., Maemura, T., Armbrust, T., Yang, J. E., Hou, Y. J., Baric, R. S., Wright, E., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104341 · Cited by 54 · see citing works

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

Tang, J., Novak, T., Hecker, J., Grubbs, G., Zahra, F. T., Bellusci, L., Pourhashemi, S., Chou, J. S., Moffitt, K. L., Halasa, N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30649-1 · Cited by 55 · see citing works

Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?

Beretta, A., Cranage, M. P., & Zipeto, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.567710 · Cited by 56 · see citing works

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms

Brown, B., Ojha, V., Fricke, I., Al-Sheboul, S. A., Imarogbe, C., Gravier, T., Green, M., Peterson, L., Koutsaroff, I. P., Demir, A. N., et al. (2023) · Vaccines · doi:10.3390/vaccines11020408 · Cited by 54 · see citing works

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection

Moga, E., Lynton‐Pons, E., & Domingo, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904686 · Cited by 46 · see citing works

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation

Sandberg, J. T., Varnaitė, R., Christ, W., Chen, P., Muvva, J. R., Maleki, K. T., García, M., Dzidic, M., Folkesson, E., Skagerberg, M., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1306 · Cited by 44 · see citing works

SARS-CoV-2—The Role of Natural Immunity: A Narrative Review

Diani, S., Leonardi, E. A., Cavezzi, A., Ferrari, S., Iacono, O., Limoli, A., Bouslenko, Z., Natalini, D., Conti, S., Mantovani, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216272 · Cited by 44 · see citing works

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection

Olukitibi, T. A., Ao, Z., Warner, B. M., Unat, R., Kobasa, D., & Yao, X. (2023) · Vaccines · doi:10.3390/vaccines11030545 · Cited by 38 · see citing works

Remembering seasonal coronaviruses

Guthmiller, J. J., & Wilson, P. C. (2020) · Science · doi:10.1126/science.abf4860 · Cited by 40 · see citing works

How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: An expert opinion by IMIDS study group

Ferretti, F., Cannatelli, R., Benucci, M., Carmagnola, S., Clementi, E., Danelli, P., Dilillo, D., Fiorina, P., Galli, M., Gallieni, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656362 · Cited by 39 · see citing works

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations

Anderson, E. M., Li, S. H., Awofolaju, M., Eilola, T., Goodwin, E. C., Bolton, M. J., Gouma, S., Manzoni, T. B., Hicks, P. D., Goel, R. R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111496 · Cited by 35 · see citing works

Human Milk Antibodies against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with a Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers

Demers‐Mathieu, V., DaPra, C., Mathijssen, G. B., Sela, D. A., Järvinen, K. M., Seppo, A., Fels, S., & Medo, E. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041749 · Cited by 33 · see citing works

Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors

Kapoor, K., Chen, T., & Tajkhorshid, E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119761119 · Cited by 33 · see citing works

SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease

Reyes, R. A., Clarke, K., Gonzales, S. J., Cantwell, A. M., Garza, R., Catano, G., Tragus, R. E., Patterson, T. F., Bol, S. M., & Bunnik, E. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261656 · Cited by 32 · see citing works

Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study

Arroyo, R. A., Portolés, J. M., Sánchez, P. L., Zalamea, F., Furaz, K., Méndez, Á., Nieto, L., Sánchez-Hernández, R., Pizarro, S. O., García, A., et al. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab048 · Cited by 31 · see citing works

The prevalence, predictors and outcomes of acute liver injury among patients with COVID‐19: A systematic review and meta‐analysis

Harapan, H., Fajar, J. K., Supriono, S., Soegiarto, G., Wulandari, L., Seratin, F., Prayudi, N. G., Dewi, D. P., Elsina, M. T. M., Atamou, L., et al. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2304 · Cited by 30 · see citing works

Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG

Winklmeier, S., Eisenhut, K., Taskin, D., Rübsamen, H., Gerhards, R., Schneider, C., Wratil, P. R., Stern, M., Eichhorn, P., Keppler, O. T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103659 · Cited by 30 · see citing works

Comparison of Levels of Nasal, Salivary, and Plasma Antibody to Severe Acute Respiratory Syndrome Coronavirus 2 During Natural Infection and After Vaccination

Cohen, J. I., Dropulic, L. K., Wang, K., Gangler, K., Morgan, K., Liepshutz, K., Krogmann, T. A., Ali, M. A., Qin, J., Wang, J., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac934 · Cited by 28 · see citing works

Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis

Lee, E.-J., & Oh, J. E. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0075 · Cited by 29 · see citing works

Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study

Sealy, R. E., & Hurwitz, J. L. (2021) · Microorganisms · doi:10.3390/microorganisms9081643 · Cited by 29 · see citing works

Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic

Heiskanen, A., Galipeau, Y., Little, J., Mortimer, L., Ramotar, K., Langlois, M., & Cooper, C. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13065 · Cited by 29 · see citing works

Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India

Nayak, K., Gottimukkala, K. P., Kumar, S., Reddy, E. S., Edara, V. V., Kauffman, R. C., Floyd, K. A., Mantus, G. E., Savargaonkar, D., Goel, P. K., et al. (2021) · Virology · doi:10.1016/j.virol.2021.02.002 · Cited by 28 · see citing works

Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection

Siracusano, G., Brombin, C., Pastori, C., Cugnata, F., Noviello, M., Tassi, E., Princi, D., Cantoni, D. M., Malnati, M., Maugeri, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772239 · Cited by 28 · see citing works

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

Weskamm, L. M., Fathi, A., Raadsen, M. P., Mykytyn, A. Z., Koch, T., Spohn, M., Friedrich, M., Bartels, E., Gundlach, S., Hesterkamp, T., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100685 · Cited by 28 · see citing works

Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2

Ng, K. T., Mohd-Ismail, N. K., & Tan, Y. (2021) · Vaccines · doi:10.3390/vaccines9020178 · Cited by 27 · see citing works

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2

Ahluwalia, P. K., Vaibhav, K., Ahluwalia, M., Mondal, A. K., Sahajpal, N., Rojiani, A. M., & Kolhe, R. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660019 · Cited by 25 · see citing works

The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐19

Hennings, V., Thörn, K., Albinsson, S., Lingblom, C., Andersson, K. M., Andersson, C., Järbur, K., Pullerits, R., Idorn, M., Paludan, S. R., et al. (2022) · European Journal of Immunology · doi:10.1002/eji.202149655 · Cited by 26 · see citing works

Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity

Jia, L., Weng, S., Wu, J., Tian, X., Zhang, Y., Wang, X., Wang, J., Yan, D., Wang, W., Fang, F., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2117503 · Cited by 27 · see citing works

Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits

Banerjee, A., Ganguly, U., Saha, S., Chakrabarti, S., Saini, R., Rawal, R., Saso, L., & Chakrabarti, S. (2021) · Expert Review of Anti-Infective Therapy · doi:10.1080/14787210.2021.1905519 · Cited by 9 · see citing works

SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines

Sunagar, R., Singh, A., & Kumar, S. (2023) · Vaccines · doi:10.3390/vaccines11040849 · Cited by 28 · see citing works

Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve

Carbonare, L. D., Valenti, M. T., Bisoffi, Z., Piubelli, C., Pizzato, M., Accordini, S., Mariotto, S., Ferrari, S., Minoia, A., Bertacco, J., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00039-7 · Cited by 24 · see citing works

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG

Li, F. F., Liu, A. C., Gibbs, E., Tanunliong, G., Marquez, A. C., Gantt, S. M., Frykman, H., Krajden, M., Morshed, M. G., Prystajecky, N., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.105050 · Cited by 25 · see citing works

Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection

Yuen, R. R., Steiner, D., Pihl, R. M. F., Chavez, E. C., Olson, A., Smith-Mahoney, E. L., Baird, L. A., Korkmaz, F. T., Urick, P., Sagar, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614676 · Cited by 21 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses

Lawrenz, J., Xie, Q., Zech, F., Weil, T., Seidel, A., Krnavek, D., van der Hoek, L., Münch, J., Müller, J. A., & Kirchhoff, F. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac057 · Cited by 25 · see citing works

The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2

Guenthoer, J., Garrett, M. E., Lilly, M., Depierreux, D., Ruiz, F., Chi, M., Stoddard, C. I., Chohan, V., Yaffe, Z. A., Sung, K., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012383 · Cited by 24 · see citing works

A Paper-Based Multiplexed Serological Test to Monitor Immunity against SARS-COV-2 Using Machine Learning

Eryılmaz, M., Goncharov, A., Han, G., Joung, H., Ballard, Z. S., Ghosh, R., Zhang, Y., Carlo, D. D., & Özcan, A. (2024) · ACS Nano · doi:10.1021/acsnano.4c02434 · Cited by 23 · see citing works

Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes

Moody, R., Sonda, S., Johnston, F. H., Smith, K. J., Stephens, N., McPherson, M., Flanagan, K. L., & Plebanski, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945021 · Cited by 23 · see citing works

SARS‐CoV ‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice

Song, S., Kim, H., Jang, E. Y., Jeon, H.-M., Diao, H., Khan, M. R. I., Lee, M., Lee, Y. J., Nam, J., Kim, S., et al. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13908 · Cited by 23 · see citing works

A Novel 3-Gene Signature for Identifying COVID-19 Patients Based on Bioinformatics and Machine Learning

Lai, G., Liu, H., Deng, J., Li, K., & Xie, B. (2022) · Genes · doi:10.3390/genes13091602 · Cited by 22 · see citing works

A Nanoparticle Vaccine Displaying Conserved Epitopes of the Preexisting Neutralizing Antibody Confers Broad Protection against SARS-CoV-2 Variants

Wu, X., Li, W., Rong, H., Pan, J., Zhang, X., Hu, Q., Shi, Z., Zhang, X., & Cui, Z. (2024) · ACS Nano · doi:10.1021/acsnano.4c03075 · Cited by 22 · see citing works

Of Cross-immunity, Herd Immunity and Country-specific Plans: Experiences from COVID-19 in India

Chakrabarti, S. S., Kaur, U., Singh, A. K., Chakrabarti, S., Krishnatreya, M., Agrawal, B. K., Mittal, A., Singh, A. K., Khanna, R., Gambhir, I. S., et al. (2020) · Aging and Disease · doi:10.14336/ad.2020.1104 · Cited by 22 · see citing works

Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19

Pinotti, F., Wikramaratna, P. S., Obolski, U., Paton, R. S., Damineli, D. S. C., Alcântara, L. C. J., Giovanetti, M., Gupta, S., & Lourenço, J. (2021) · BMC Medicine · doi:10.1186/s12916-020-01887-1 · Cited by 19 · see citing works

Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays

Köppert, S., Wolf, C., Becza, N., Sautto, G. A., Franke, F., Küerten, S., Ross, T. M., Lehmann, P., & Kirchenbaum, G. A. (2021) · Cells · doi:10.3390/cells10081843 · Cited by 19 · see citing works

Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative

Kyei-Barffour, I., Addo, S. A., Aninagyei, E., Ghartey-Kwansah, G., & Acheampong, D. O. (2021) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2021.112282 · Cited by 12 · see citing works

Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel

Ng, K. W., Faulkner, N., Wrobel, A. G., Gamblin, S. J., & Kassiotis, G. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101507 · Cited by 19 · see citing works

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

Fathi, A., Dahlke, C., Krähling, V., Kupke, A., Okba, N. M. A., Raadsen, M. P., Heidepriem, J., Müller, M. A., Paris, G., Lassen, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31557-0 · Cited by 20 · see citing works

Bovine Coronavirus Immune Milk Against COVID-19

Arenas, A. J., Borge, C., Carbonero, A., García‐Bocanegra, I., Cano‐Terriza, D., Caballero‐Gómez, J., & Arenas‐Montes, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637152 · Cited by 20 · see citing works

Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation

Olmedillas, E., Rajamanickam, R. R., Avalos, R. D., Ana-Sosa-Batiz, F., Zyla, D., Zandonatti, M. A., Harkins, S. S., Shresta, S., Hastie, K. M., & Saphire, E. O. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116052 · Cited by 19 · see citing works

Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases

Herman, J. D., Atyeo, C. G., Zur, Y., Cook, C., Patel, N. J., Vanni, K. M. M., Kowalski, E., Qian, G., Srivatsan, S., Shadick, N. A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf6598 · Cited by 26 · see citing works

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

Woopen, C., Schleußner, K., Akgün, K., & Ziemssen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701752 · Cited by 18 · see citing works

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?

Gussarow, D., Bonifacius, A., Cossmann, A., Stankov, M. V., Mausberg, P., Tischer‐Zimmermann, S., Gödecke, N., Kalinke, U., Behrens, G. M. N., Blasczyk, R., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.770381 · Cited by 18 · see citing works

Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity

Williams, J. A., Biancucci, M., Lessen, L. N., Tian, S., Balsaraf, A., Chen, L., Chesterman, C. C., Maruggi, G., Vandepaer, S., Huang, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg0330 · Cited by 18 · see citing works

Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam

Nguyen, T. T. N., Choo, E. M., Nakamura, Y., Suzuki, R., Shiina, T., Shin‐I, T., Fukuta, M., Nguyen, C. T., Nguyen, T. T. T., Nguyen, L. K. H., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.11.008 · Cited by 18 · see citing works

Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography

Wang, J., Li, D., Zhou, Q., Wiltse, A., & Zand, M. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696370 · Cited by 17 · see citing works

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada

Tanunliong, G., Liu, A. C., Kaweski, S. E., Irvine, M. A., Reyes, R. C., Purych, D., Krajden, M., Morshed, M. G., Sekirov, I., Gantt, S. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836449 · Cited by 16 · see citing works

MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans

Mayer, L., Weskamm, L. M., Fathi, A., Kono, M., Heidepriem, J., Krähling, V., Mellinghoff, S. C., Ly, M. L., Friedrich, M., Hardtke, S., et al. (2024) · npj Vaccines · doi:10.1038/s41541-023-00801-z · Cited by 16 · see citing works

SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract

Escalera, A., Rojo-Fernandez, A., Rombauts, A., Abelenda-Alonso, G., Carratalà, J., García‐Sastre, A., & Aydillo, T. (2024) · iScience · doi:10.1016/j.isci.2024.109210 · Cited by 16 · see citing works

COVID ‐19 antibody screening with SARS‐CoV ‐2 red cell kodecytes using routine serologic diagnostic platforms

Nagappan, R., Flegel, W. A., Srivastava, K., Williams, E. C., Ryzhov, I. M., Tuzikov, A. B., Galanina, O. E., Shilova, N. V., Sukhikh, G. T., Perry, H. E., et al. (2021) · Transfusion · doi:10.1111/trf.16327 · Cited by 16 · see citing works

Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy

Trivedi, V. S., Magnusen, A. F., Rani, R., Marsili, L., Slavotinek, A. M., Prows, D. R., Hopkin, R. J., McKay, M. A., & Pandey, M. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214340 · Cited by 15 · see citing works

Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide

Vanderheijden, N., Stevaert, A., Xie, J., Ren, X., Barbezange, C., Noppen, S., Desombere, I., Verhasselt, B., Geldhof, P., Vereecke, N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790415 · Cited by 15 · see citing works

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity

Wang, J., Li, D., Cameron, A., Zhou, Q., Wiltse, A., Nayak, J. L., Pecora, N., & Zand, M. S. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac022 · Cited by 15 · see citing works

Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic—Experience and Outlines

Neagu, M. T., Constantin, C., & Surcel, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182413173 · Cited by 12 · see citing works

Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers

Egwang, T. G., Owalla, T. J., Okurut, E., Apungia, G., Fox, A., Carlo, C. D., & Powell, R. L. R. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.039 · Cited by 12 · see citing works

Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity

Cano‐Muñoz, M., Polo-Megías, D., Cámara-Artigas, A., Gavira, J. A., López-Rodríguez, M. J., Laumond, G., Schmidt, S., Demiselle, J., Bahram, S., Moog, C., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.031 · Cited by 13 · see citing works

Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals

Embong, A., Nguyen-Contant, P., Wang, J., Kanagaiah, P., Chaves, F., Fitzgerald, T., Zhou, Q., Kosoy, G., Branche, A., Miller, B. L., et al. (2022) · Pathogens · doi:10.3390/pathogens11020186 · Cited by 4 · see citing works

Dominant and cross-reactive S1-specific memory B cell response induced by primary SARS-CoV-2 infection

Xing, X., Zhang, Z., Wen, Y., Guo, W., Zhang, X., Min, Y., Zhong, K., Zhang, L., Wei, P., Zhang, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-06847-4 · Cited by 1 · see citing works

Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection

Song, G., He, W.-T., Callaghan, S., Anzanello, F., Huang, D.-L., Ricketts, J., Torres, J., Beutler, N., Peng, L., Vargas, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23074-3 · Cited by 158 · see citing works

mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection

Casado, J. L., Vizcarra, P., Martín-Hondarza, A., Gómez-Maldonado, S., Muedra-Sánchez, M., del Pino, J., Mirabella, I. G., Martín-Colmenarejo, S., Häemmerle, J., Fernández-Escribano, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127379

SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination

Teng, S., Hu, Y., Wang, Y., Tang, Y., Wu, Q., Zheng, X., Lü, R., Pan, D., Liu, F., Xie, T., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1355949 · Cited by 8 · see citing works